Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Invested Capital: 2019-2025

Historic Invested Capital for Revolution Medicines (RVMD) over the last 7 years, with Sep 2025 value amounting to $1.6 billion.

  • Revolution Medicines' Invested Capital rose 1.95% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 1.95%. This contributed to the annual value of $2.3 billion for FY2024, which is 24.04% up from last year.
  • According to the latest figures from Q3 2025, Revolution Medicines' Invested Capital is $1.6 billion, which was down 14.39% from $1.9 billion recorded in Q2 2025.
  • Revolution Medicines' 5-year Invested Capital high stood at $2.3 billion for Q4 2024, and its period low was $498.8 million during Q2 2022.
  • Its 3-year average for Invested Capital is $1.6 billion, with a median of $1.6 billion in 2024.
  • As far as peak fluctuations go, Revolution Medicines' Invested Capital fell by 27.18% in 2022, and later spiked by 166.52% in 2023.
  • Revolution Medicines' Invested Capital (Quarterly) stood at $602.6 million in 2021, then grew by 13.71% to $685.2 million in 2022, then soared by 166.52% to $1.8 billion in 2023, then grew by 24.04% to $2.3 billion in 2024, then grew by 1.95% to $1.6 billion in 2025.
  • Its Invested Capital stands at $1.6 billion for Q3 2025, versus $1.9 billion for Q2 2025 and $2.1 billion for Q1 2025.